Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications

Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications

Transthyretin cardiac amyloidosis (ATTR-CA) is a challenging and underdiagnosed cause of heart failure. Advances in cardiac imaging have enabled noninvasive diagnosis of ATTR-CA, causing the recent upsurge in disease awareness and detection. ATTR-CA has been increasingly recognized in patients with...

Full description

Bibliographic Details
Main Authors: Giedre Balciunaite, Arnas Rimkus, Edvardas Zurauskas, Tomas Zaremba, Darius Palionis, Nomeda Valeviciene, Audrius Aidietis, Pranas Serpytis, Kestutis Rucinskas, Peter Sogaard, Sigita Glaveckaite, Aleksejus Zorinas, Vilius Janusauskas
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Hellenic Journal of Cardiology
Subjects:
Aortic stenosis
Cardiac amyloidosis
Transthyretin
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966619302787

Internet

http://www.sciencedirect.com/science/article/pii/S1109966619302787

Similar Items